Trandolapril and Verapamil

Angiotensin Converting Enzyme Inhibitor

NADAC/unit N/A

No Shortage Tier 1: 66.6% 1 Manufacturers 4 ANDAs

Covered Lives

Market Intelligence

2023-08-30 Class III Recall: Glenmark Pharmaceuticals Inc., USA

Generic Manufacturers

GLENMARK PHARMACEUTICALS LTD

Explore in the Ecosystem

rxsaver.aiCompare prices for Trandolapril and Verapamil drfinder.aiFind doctors who prescribe Trandolapril and Verapamil rxnews.aiLatest news about Trandolapril and Verapamil

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.